WAL0921

· Walden Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WAL0921, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of WAL0921 in Patients With Glomerular Kidney Diseases [Phase 2]